Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11432017rdf:typepubmed:Citationlld:pubmed
pubmed-article:11432017lifeskim:mentionsumls-concept:C0001973lld:lifeskim
pubmed-article:11432017lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:11432017lifeskim:mentionsumls-concept:C0027360lld:lifeskim
pubmed-article:11432017lifeskim:mentionsumls-concept:C0284941lld:lifeskim
pubmed-article:11432017pubmed:issue5lld:pubmed
pubmed-article:11432017pubmed:dateCreated2001-7-2lld:pubmed
pubmed-article:11432017pubmed:abstractTextTwo new drugs for the treatment of alcohol dependence have recently become available in Australia. Both naltrexone and acamprosate have an 'anticraving' action, but act on different pathways and have different properties.lld:pubmed
pubmed-article:11432017pubmed:languageenglld:pubmed
pubmed-article:11432017pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11432017pubmed:citationSubsetIMlld:pubmed
pubmed-article:11432017pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11432017pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11432017pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11432017pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11432017pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11432017pubmed:statusMEDLINElld:pubmed
pubmed-article:11432017pubmed:monthMaylld:pubmed
pubmed-article:11432017pubmed:issn0300-8495lld:pubmed
pubmed-article:11432017pubmed:authorpubmed-author:TedeschiMMlld:pubmed
pubmed-article:11432017pubmed:issnTypePrintlld:pubmed
pubmed-article:11432017pubmed:volume30lld:pubmed
pubmed-article:11432017pubmed:ownerNLMlld:pubmed
pubmed-article:11432017pubmed:authorsCompleteYlld:pubmed
pubmed-article:11432017pubmed:pagination447-50lld:pubmed
pubmed-article:11432017pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:meshHeadingpubmed-meshheading:11432017...lld:pubmed
pubmed-article:11432017pubmed:year2001lld:pubmed
pubmed-article:11432017pubmed:articleTitleNaltrexone and acamprosate. Using new drugs for alcohol dependence.lld:pubmed
pubmed-article:11432017pubmed:affiliationACT Alcohol and Drug Program, Canberra Hospital, ACT.lld:pubmed
pubmed-article:11432017pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11432017pubmed:publicationTypeReviewlld:pubmed